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The human protein CD36 is a major receptor for Plasmodium falciparum–infected erythrocytes and contributes
to the pathology of P. falciparum malaria. We performed variation screening of the CD36 gene and examined the
possible association between CD36 polymorphisms and the severity of malaria in 475 adult Thai patients with P.
falciparum malaria. Accordingly, we identified nine CD36 polymorphisms with a high-frequency (115%) minor
allele. Of these, the frequencies of the 514TrC allele in the upstream promoter region and the 553GrT allele
in the downstream promoter region were significantly decreased in patients with cerebral malaria compared to
those with mild malaria ( for 514TrC and for 553GrT). The analysis of linkage disequi-Pp .016 Pp .050
librium (LD) between the nine common polymorphisms revealed that there are two blocks with strong LD in the
CD36 gene and that the 514TrC and 553GrT polymorphisms are within the upstream block of 35 kb from
the upstream promoter to exon 8. Further association testing after the second variation screening in the upstream
block indicated that the in3(TG)12 (i.e., 12 TG repeats in intron 3) allele is most strongly associated with the
reduction in the risk of cerebral malaria (odds ratio 0.59; 95% confidence interval 0.40–0.87; ). WePp .0069
found, by reverse-transcriptase PCR amplification, that in3(TG)12 is involved in the nonproduction of the variant
CD36 transcript that lacks exons 4 and 5. Since exon 5 of the gene is known to encode the ligand-binding domain
for P. falciparum–infected erythrocytes, in3(TG)12 itself or a primary variant on the haplotype with in3(TG)12 may
be responsible for protection from cerebral malaria in Thailand. Results of the present study suggest that LD
mapping has potential for detecting a disease-associated variant on the basis of haplotype blocks.
Introduction
Plasmodium falciparum malaria remains a major cause
of morbidity and mortality in tropical countries, affect-
ing 300 million people and causing more than two mil-
lion deaths each year. One of the peculiar features of P.
falciparum malaria is the adhesion of parasite-infected
erythrocytes to capillary endothelia (Miller et al. 1994,
2002). This adhesion contributes to the pathology of P.
falciparum malaria, since it causes local microvascular
occlusion (Patnaik et al. 1994) and inhibits the immune
response to parasites (Urban et al. 1999). A number
of receptors have been implicated in cytoadherence
of infected erythrocytes—including thrombospondin
(Roberts et al. 1985), intercellular adhesion molecule 1
(Berendt et al. 1989), vascular cell adhesion molecule 1
(Ockenhouse et al. 1992), chondroitin sulfate A (Ro-
gerson et al. 1995), platelet/endothelial cell adhesion
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molecule 1/CD31 (Treutiger et al. 1997), and CD36.
Since almost all adherence-positive P. falciparum strains
and isolates bind to CD36 (Newbold et al. 1997), CD36
plays the predominant role in the adherence of infected
erythrocytes (Ockenhouse et al. 1989, 1991).
CD36 is an 88-kDa glycoprotein expressed on various
cells, such as platelets, erythroblasts, adipocytes, mono-
cytes, dendritic cells, macrophages, and vascular en-
dothelial cells. CD36 is involved in a variety of functions
in lipid transport, immune regulation, hemostasis, and
angiogenesis (Greenwalt et al. 1992; Febbraio et al.
2001). The adhesion of P. falciparum–infected erythro-
cytes to CD36 may be of benefit to malaria parasites by
the sequestration of infected erythrocytes from circula-
tion and by the inhibition of the immune response to
parasites (Urban et al. 1999). Pain et al. (2001a) have
reported that platelet-mediated clumping of P. falci-
parum–infected erythrocytes is strongly associated with
severe malaria and that CD36 expression is required
for such clumping. In contrast, CD36 on monocytes and
macrophages has been reported to be necessary for the
CD36-dependent phagocytosis of P. falciparum–
infected erythrocytes (McGilvray et al. 2000). Thus,
CD36 (MIM 173510) is a candidate gene for influenc-
ing the outcome of malaria infection.
The human CD36 gene is encoded by 16 exons ex-
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tending across 146 kb on chromosome 7q11.2 (Ar-
mesilla and Vega 1994; Sato et al. 2002). A marked
feature of this gene is the presence of two alternative
and independent first exons and their promoters, sep-
arated by ∼14 kb (Sato et al. 2002). Recently, the
1264TrG stop mutation, causing CD36 deficiency, was
found to be associated with protection from severe
malaria in Africa (Pain et al. 2001), whereas a con-
trasting report demonstrates the association between
the 1264TrG polymorphism and susceptibility to ce-
rebral malaria (Aitman et al. 2000). Although possible
associations between CD36 polymorphisms and severe
malaria have been examined in African patients with
malaria, CD36 polymorphisms have, to our knowledge,
never been studied in Asian patients.
In the present study, we first analyzed 1264TrG and
screened for variations in all 16 exons and two promoter
regions of CD36 in Thai patients with malaria. A pos-
sible association between the identified polymorphisms
and the severity of malaria was examined in 272 adult
patients with severe P. falciparum malaria and 203 pa-
tients with mild malaria. To our knowledge, this is the
first association analysis of CD36 polymorphisms de-
tected by systematic variation screening of the CD36
gene.
Patients and Methods
Patients
A total of 272 adult patients with severe P. falciparum
malaria (108 patients with cerebral malaria and 164
patients with noncerebral severe malaria) and 203 adult
patients with mild P. falciparum malaria (control indi-
viduals), all of whom live in northwestern Thailand,
were enrolled in the present study. All of them underwent
treatment at the Hospital for Tropical Diseases, Faculty
of Tropical Medicine, Mahidol University.
Clinical manifestations of malaria were classified as
follows. Cerebral malaria was characterized by coma,
positive blood smear for the asexual form of P. falci-
parum, and exclusion of other causes of coma. Severe,
but not cerebral, malaria (i.e., noncerebral severe ma-
laria) was characterized by one of the following symp-
toms: high parasitemia (1100,000 parasites/ml), hypo-
glycemia (glucose !22 nmol/liter), severe anemia
(hematocrit !20% or hemoglobin !7.0 g/dl), and in-
creased serum creatinine levels (13.0 mg/dl). Mild ma-
laria was characterized by a positive blood smear, fever
without other causes of infection, and no manifestations
of severe malaria as described above.
All individuals were 13 years of age, and the mean
ages of the patients with severe malaria and mild malaria
were both 25.5 years. Genomic DNA was extracted from
peripheral-blood leukocytes by using a QIAamp Blood
Kit (Qiagen). The present study was approved by the
institutional review board of the Faculty of Tropical
Medicine, Mahidol University, and informed consent
was obtained from all patients.
Genotyping of the 1264TrG Polymorphism
The 1264TrG polymorphism was analyzed by PCR
direct sequencing with forward primer ex10F (5′-AGTT-
CAGGTTCCTGGAATGC-3′) and reverse primer ex10R
(5′-ATGGACTGTGCTACTGAGGT-3′). The PCR prod-
ucts of 90 samples randomly chosen from patients with
severe and mild malaria were used for direct sequencing
with an ABI Prism 3100 Genetic Analyzer (Applied
Biosystems).
Nucleotide Sequencing
Variation screening of all 16 exons with neighbor-
ing introns and two promoter regions of CD36 was
performed by PCR direct sequencing. For the pro-
moter regions, sequences spanning positions 1
through 773 (nucleotides 1183-1955 in GenBank
clone AF434768), for the upstream promoter, and po-
sitions 1 through 708 (nucleotides 3608–4316 in
GenBank clone AF434767), for the downstream pro-
moter, were analyzed, since these regions have been re-
ported to include putative regulatory elements for tran-
scriptional factors. The first screening panel included 16
patients with malaria. In the second screening, to in-
crease the probability of detecting any rare variants, we
increased the numbers of screened patients with malaria
for exons 1, 2, 3, 4, 5, 6, and 7 and the upstream and
downstream promoter regions to 32, 32, 32, 54, 36, 36,
32, 36, and 36, respectively. Each fragment amplified by
PCR from genomic DNA was sequenced on both strands
with an ABI Prism 3100 Genetic Analyzer.
Genotyping of the Identified Polymorphisms
The identified polymorphisms were named tentatively
for convenience (table 1). Each polymorphism was ge-
notyped by one of five methods: direct sequencing (for
the 5′flankingIndel1, 5′flankingSNP1, and 5′UTRSNP2
polymorphisms), PCR-SSCP (for the 88CrG,
5′flankingSNP3, 5′UTRSNP4, 669CrT, in7SNP6, and
in11SNP8 polymorphisms), fluorescence-resonance en-
ergy transfer (FRET) (for the in3SNP5 polymorphism),
PCR-RFLP analysis (for the in8SNP7 polymorphism),
or electrophoretic gel–based detection of allele-length
difference (for the 3′UTRIndel2 and in14Indel3 poly-
morphisms). The PCR primers and the annealing tem-
peratures are listed in table 1.
The 5′flankingIndel1, 5′flankingSNP1, and 5′UTRSNP2
polymorphisms were genotyped by direct sequencing of
a single 560-bp PCR product encompassing these sites.
Genotyping of 88CrG, 5′flankingSNP3, 5′UTRSNP4,
Table 1
Overview of CD36 Polymorphisms Identified in Thai
Polymorphism Nucleotide Substitution (Position)a
Genotyping
Method Sequenceb Forward and Reverse Primers
Annealing
Temperature
(C)
First screening:
5′flankingIndel1 136insCAAA (upstream promoter) Sequencing ggagaggttaacaaaCAAAcactggctgcaaga 5′-TGTTGTTATGTGGTTCCTAG-3′,
5′-CAAAAGTCAGATCAAAGTAG-3′
52
5′flankingSNP1 14TrC (upstream promoter) Sequencing atgtacagcagtgatT/Ctgacccagcacttg 5′-TGTTGTTATGTGGTTCCTAG-3′,
5′-CAAAAGTCAGATCAAAGTAG-3′
52
5′UTRSNP2 59TrA (exon 1a) Sequencing tcccaactagcattcT/Agaaagtgcattaaca 5′-TGTTGTTATGTGGTTCCTAG-3′,
5′-CAAAAGTCAGATCAAAGTAG-3′
52
5′flankingSNP3 53GrT (downstream promoter) PCR-SSCP ctcttctctttttttG/Tggggggggagggggt 5′-CTTTCAATTCCTCTGGCAAC-3′,
5′-AAGTCCTACACTGCAGTCC-3′
58
5′UTRSNP4 158CrA (exon 2) PCR-SSCP ctgactcatcagttcA/Ctttcctgtaaaattca 5′-TGATATTAGAGAGTGTCCC-3′,
5′-ATAAGCAAGTATGGTAACAG-3′
56
in3SNP5 IVS3-6TrC (intron 3) PCR-FRET aacttattttcttttT/Ccatagcaagttgtcc 5′-TAAATTATGTTGACTGTTGC-3′,
5′-ACTCACTCACCTGTACG-3′
52
in7SNP6 IVS7103CrT (intron 7) PCR-SSCP catcaacctatagaaC/Tagacctggttataat 5′-TGTATCTTCTTTGTCACAGC-3′,
5′-TAACACAACCATAACCTGTG-3′
56
in8SNP7 IVS8-156ArG (intron 8) PCR-RFLP ccagcatgcctggccA/Ggttatttctttttac 5′-TATGATCTGGCTACCTAATG-3′,
5′-CATTTACTTCTGTTGCCAG-3′
58
in11SNP8 IVS11-150ArC (intron 11) PCR-SSCP tgcatgtgtatataaA/Ctataactatatatgc 5′-AAACCTTGACATTCGATTGG-3′,
5′-CATAGAAATATTTGGGCAGC-3′
56
3′UTRIndel2 1946-61delGCACAAATAAAGCACT (exon 14) PCR accattgtaacaataGCACAAATAAAGCACTtgtgccaaagttgtc 5′-AATATTATCACGCAGATCAC-3′,
5′-AATTGAGAAATGAACCAGTC-3′
53
in14Indel3 IVS14-419delGGGTTGAGA (intron 14) PCR cttgtcttgaGGGTTGAGAagcacccttc 5′-GAACTTGGTCTGAAGGGTG-3′,
5′-AGGCACATAAGAAGGGTGC-3′
60
Second screening:
88CrG 88CrG (downstream promoter) PCR-SSCP accacacactgggatC/Gtgacactgtagagtg 5′-ATGTTAGGGGAAACTCAGC-3′,
5′-AAAGAGAAGAGAAAGCACTC-3′
56
669CrT 669CrT (Ser127Leu) (exon 5) PCR-SSCP tcgaaccttcactatC/Tagttggaacagaggc 5′-CGTTAGTTTGCTAGAGACC-3′,
5′-TCTTCTAATGCAGTCGATTC-3′
54
a The nucleotide sequence described by Sato et al. (2002) was used as the reference sequence of the recently described exon 1a and upstream promoter region; the nucleotide sequence described by Armesilla
and Vega (1994) was used as the reference sequence of other regions.
b The nucleotides denoted by capital letters indicate the polymorphisms; the nucleotide to the left of a slash mark (/) is the more frequently observed allele at the SNP site in Thai patients with malaria.
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669CrT, in7SNP6, and in11SNP8 was performed by
PCR-SSCP; the samples of those genotypes that have
been confirmed by direct sequencing were used as ref-
erences in the PCR-SSCP analysis. Genotyping of
in8SNP7 was performed using the PCR-RFLP method;
after PCR, the amplified products containing the poly-
morphic site were digested with MspI for 3 h and were
analyzed on a 10% polyacrylamide gel. Genotyping
for in3SNP5 was performed by the FRET method, using
a LightCycler (Roche Diagnostics), according to the
manufacturer’s instructions; the sequences of the fluo-
rescein and LCRed probes used were 5′-ACTTGCTA-
TGGAAAAGAAAA-3′ and 5′-AAGTTTGGGTTAT-
GTCTTTGTAGTAAGTACAGGCACTTCTGGAAGA-
TTGT-3′, respectively; and, after amplification, geno-
types were determined by melting-curve analysis. The
3′UTRIndel2 and in14Indel3 polymorphisms were ge-
notyped by the amplification of a fragment containing
the deleted region, followed by the measurement of the
allele size by gel electrophoresis with a 10% polyacryl-
amide gel.
Genotyping of the TG Repeat Polymorphism
Genotyping of the dinucleotide repeat, in3(TG)n (i.e.,
the TG repeat polymorphism in intron 3), of the CD36
gene was performed by PCR, followed by use of an ABI
377 Automated Sequencer (PE Applied Biosystems). The
sequence of primers comprised a forward primer (5′-
ATTTATAAAAGAAGTTGCAC-3′, with FAM-labeling
at the 5′ end) and a reverse primer (5′-GTTTACCTACA-
ATTTAATAA-3′). The PCR fragments were sized using
the GeneScan Analysis Software (version 2.1; PE Applied
Biosystems), as described in the manufacturer’s manual.
A control sample with a known repeat number was
tested as a quality control on each gel.
Identification of Variant CD36 Transcript by RT-PCR
Total RNA was purified from peripheral-blood mono-
nuclear cells (PBMC) from unaffected Japanese volun-
teers by using the RNeasy Mini Kit (Qiagen) and was
then reverse transcribed into cDNA. The cDNA ampli-
fications for detecting the variant CD36 transcript were
performed in a total volume of 50 ml containing 1.5 ml
cDNA, 0.2 mM forward primer ex3-6F (5′-CAATTAAA-
AAGGCTGCATCC-3′), 0.2 mM reverse primer ex7R (5′-
TATGTGTCGATTATGGCAAC-3′), 0.4 mM dNTPs,
2.5 mM MgCl2, and 2 U Taq polymerase. Primer ex3-
6F was designed to bind to the junction sequence of
exons 3 and 6, which exclusively amplify the variant
CD36 cDNAs that lack exons 4 and 5, even though they
are present at low levels. The condition for the ampli-
fication of the variant CD36 cDNAs consisted of an
initial denaturation at 96C for 10 min, followed by 40
cycles of denaturation at 96C for 30 s, annealing at
54C for 30 s, and extension at 72C for 30 s. It has
been reported that various alternative splicing tran-
scripts of CD36 were observed in human PBMC,
whereas exons 2 and 3 were observed in all identified
transcripts (Kern et al. 1999). Therefore, to confirm the
presence of the CD36 transcript, we amplified CD36
cDNAs through exons 2 and 3 by using forward primer
ex2F (5′-GCTGTTGATTTGTGAATAAG-3′) and re-
verse primer ex3R (5′-TGTCTTCTGGATAAGCAGG-
3′). The condition for the amplification consisted of an
initial denaturation at 96C for 10 min, followed by 33
cycles of denaturation at 96C for 30 s, annealing at
56C for 30 s, and extension at 72C for 30 s. Glycer-
aldehyde phosphate dehydrogenase (GAPDH) cDNAs
were amplified as internal controls (Møller et al. 2000).
Statistical Analyses
The x2 test, Fisher’s exact test, and x2 test for trend
(Armitage’s trend test) were used to compare the fre-
quencies of the CD36 polymorphisms among the three
groups of patients with malaria. Fisher’s exact test was
used when one or more cells in a contingency2 # 2
table contained a value of less than five. Conformity of
the genotype proportion to Hardy-Weinberg equilibrium
was examined for each polymorphism in each group of
patients with malaria.
To assess the extent of pairwise linkage disequilibrium
(LD) between polymorphisms, we calculated Lewontin’s
D′ (Lewontin 1964) by using the program LDfinder (de-
veloped by J.O.), in which haplotype frequencies be-
tween two biallelic polymorphisms are estimated on the
basis of an expectation-maximization algorithm (Ex-
coffier and Slatkin 1995). Throughout the present ar-
ticle, D′ and haplotype frequencies were calculated only
for polymorphisms with a minor-allele frequency 115%.
D′ was further assessed for 40 and 33 publicly available
polymorphisms in the region between intron 3 and in-
tron 14 of CD36 in 24 African-descent (AD) Americans
and in 23 European-descent (ED) Americans, respec-
tively, on the basis of genotype data from the UW-
FHCRC Variation Discovery Resource (National Heart,
Lung, and Blood Institute Program for Genomic Appli-
cations). Pairwise D′ was plotted using the GOLD pro-
gram (see the GOLD Home Page) (Abecasis and Cook-
son 2000). For each pair of polymorphisms, D′ was
plotted at the Cartesian coordinates corresponding to
the polymorphism location on the physical map.
Frequencies of haplotypes defined by 10 polymor-
phisms were estimated on the basis of a maximum-like-
lihood method with an expectation-maximization al-
gorithm (Excoffier and Slatkin 1995). The calculation
was performed using the program Arlequin (Schneider
et al. 2000).
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Figure 1 Graphical representation of identified polymorphisms and the TG repeat in intron 3, in relation to the exon-intron structure of
the human CD36 gene.
Results
Lack of the 1264TrG Polymorphism in Thai Patients
with Malaria
In recent years, the role that CD36 polymorphisms
play in patients with P. falciparum malaria has been a
major subject of research. There are two contradictory
reports on the association between the CD36 polymor-
phism (1264TrG) and the severity of malaria in African
populations (Aitman et al. 2000; Pain et al. 2001). How-
ever, 1264TrG was not detected in 180 chromosomes
in the present study. We therefore concluded that this
polymorphism does not significantly contribute to the
severity of malaria in Thai.
First Screening and Identified Polymorphisms
In the first screening, 11 polymorphisms were iden-
tified: 8 SNPs, 1 insertion, and 2 deletions (SNP1–SNP8
and Indel1–Indel3 in fig. 1 and table 1). Of these 11
polymorphisms, 9 were common and had a minor-allele
frequency 115%.
Table 2 summarizes the allele frequencies of CD36
polymorphisms in 475 Thai patients with malaria.
Among these polymorphisms, the frequency of the C
allele of 5′flankingSNP1 was found to be decreased in
patients with cerebral malaria compared to that in pa-
tients with mild malaria (odds ratio [OR] 0.62; 95% CI
0.42–0.92; ). The frequency of the T allele ofPp .016
5′flankingSNP3 was moderately decreased in patients
with cerebral malaria compared to that in patients with
mild malaria ( ; 95% CI 0.47–1.0;ORp 0.68 Pp
). No statistically significant difference was observed.050
for the other polymorphisms either between patients
with cerebral malaria and mild malaria or between pa-
tients with noncerebral severe malaria and mild malaria.
None of the polymorphisms in each group deviated from
expectations based on Hardy-Weinberg equilibrium at
a significance level of .05.
The 5′flankingSNP1 and 5′flankingSNP3 polymor-
phisms showed a significant association with protection
from cerebral malaria. However, such an association can
be caused by LD between the polymorphisms and a pri-
mary associated polymorphism in CD36. To determine
the extent of LD in the CD36 gene, we analyzed pairwise
D′ between the nine polymorphisms common in Thai
patients with malaria.
Structure of LD in CD36
The pairwise D′ between the nine polymorphisms with
a high-frequency (115%) minor allele in Thai patients
with malaria is shown in figure 2a. There was no marked
difference in D′ between patients with cerebral and mild
malaria. Therefore, the LD profile in patients with ma-
laria does not seem to be affected by the differences in
allele frequency. Figure 2a suggests the presence of two
blocks of strong LD in the CD36 gene. The boundary
between the two blocks exists around in7SNP6, and
5′flankingSNP1 and 5′flankingSNP3 are located in the
upstream block. Thus, the upstream block is considered
to contain the primary polymorphism associated with
protection from cerebral malaria. The prediction of the
precise boundary between the two blocks is important,
because we can then determine the end of the region
where the primary polymorphism exists. However, the
boundary cannot be inferred precisely, because only a
small number of polymorphisms were available for the
calculation of D′ in this region.
To determine whether the two-LD-block structure ob-
served in Thai is common, we next analyzed the higher-
resolution LD profiles of the CD36 gene in AD and ED
Americans, on the basis of genotype data from the UW-
FHCRC Variation Discovery Resource. In the genomic
region of CD36, extending 29,894 bp (from exon 3 to
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Table 2
Allele Frequencies of CD36 Polymorphisms in Thai Patients with
Malaria
POLYMORPHISM
AND ALLELE
NO. (%) WITH
Cerebral
Malaria
( )2np 216
Noncerebral Severe
Malaria
( )2np 328
Mild Malaria
( )2np 406
5′flankingIndel1:
Insertion 5 (2.3) 12 (3.7) 13 (3.2)
Common 211 (97.7) 316 (96.3) 393 (96.8)
5′flankingSNP1:a
C allele 46 (21.3) 90 (27.4) 123 (30.3)
T allele 170 (78.7) 238 (72.6) 283 (69.7)
5′UTRSNP2:
A allele 71 (32.9) 108 (32.9) 116 (28.6)
T allele 145 (67.1) 220 (67.1) 290 (71.4)
5′flankingSNP3:b
T allele 49 (22.7) 92 (28.0) 122 (30.0)
G allele 167 (77.3) 236 (72.0) 284 (70.0)
5′UTRSNP4:
C allele 74 (34.3) 116 (35.4) 132 (32.5)
A allele 142 (65.7) 212 (64.6) 274 (67.5)
in3SNP5:
C allele 91 (42.1) 119 (36.3) 145 (35.7)
T allele 125 (57.9) 209 (63.7) 261 (64.3)
in7SNP6:
T allele 48 (22.2) 63 (19.2) 75 (18.5)
C allele 168 (77.8) 265 (80.8) 331 (81.5)
in8SNP7:
G allele 102 (47.2) 161 (49.1) 190 (46.8)
A allele 114 (52.8) 167 (50.9) 216 (53.2)
in11SNP8:
C allele 101 (46.8) 160 (48.8) 188 (46.3)
A allele 115 (53.2) 168 (51.2) 218 (53.7)
3′UTRIndel2:
Deletion 11 (5.0) 17 (5.2) 27 (6.7)
Common 205 (95.0) 311 (94.8) 379 (93.3)
in14Indel3:
Deletion 102 (47.2) 159 (48.5) 200 (49.3)
Common 114 (52.8) 169 (51.5) 206 (50.7)
88CrG:
G allele 2 (.9) 3 (.9) 5 (1.2)
C allele 214 (99.1) 325 (99.1) 401 (98.8)
669CrT:
T allele 1 (.5) 2 (.6) 5 (1.2)
C allele 215 (99.5) 326 (99.4) 401 (98.8)
a ; 95% CI 0.42–0.92; , and (cerebral malaria2ORp 0.62 x p 5.77 Pp .016
vs. mild malaria, by x2 test based on a contingency table).2#2
b ; 95% CI 0.47–1.0; , and (cerebral malaria2ORp 0.68 x p 3.83 Pp .050
vs. mild malaria, by x2 test based on a contingency table).2#2
intron 14), we selected 40 and 33 polymorphisms with
a high-frequency (115%) minor allele in AD and ED
Americans, respectively. The average distances between
adjacent polymorphisms were 705.3 bp in AD Ameri-
cans and 855.4 bp in ED Americans. The profiles of D′
between these polymorphisms are shown in figure 2b.
Two blocks of strong LD were again observed in both
populations. The regions with the abrupt LD breakdown
were almost identical in the two populations and ex-
tended 3 kb around exon 8 of the CD36 gene. From
figures 2a and 2b, we concluded that there are two
blocks of strong LD in the CD36 gene; these are the
upstream block, spanning 35 kb from the upstream
promoter to intron 7, and the downstream block,
spanning 8 kb from intron 8 to intron 14. Since
5′flankingSNP1 and 5′flankingSNP3 were in the up-
stream block, we then performed further screening, for
rare variations in this block, and we performed geno-
typing of in3(TG)n.
Second Screening and Identified Polymorphisms
Two polymorphisms were newly identified in the
second screening of exons 1–7 with neighboring in-
trons and upstream and downstream promoter
regions. The 88CrG polymorphism was detected in
the downstream promoter region. The 669CrT poly-
morphism, causing a nonconservative amino acid change
(Ser127Leu), was identified in exon 5. However, no sig-
nificant association was observed between these poly-
morphisms and the severity of malaria (table 2).
Throughout the present study, five novel polymorphisms
have been identified: 5′flankingIndel1 (GenBank acces-
sion number AB089812), 5′flankingSNP1 (AB088854),
5′UTRSNP2 (AB088853), 88CrG (AB088855), and
669CrT (AB088852).
The TG Repeat Polymorphism
We analyzed in3(TG)n in Thai patients with malaria.
The in3(TG)n polymorphism is a known polymorphic
marker in the CD36 gene (Lipsky et al. 1994) and has
been reported to be linked with CD36 deficiency (Kash-
iwagi et al. 1995). As shown in table 3, the number of
TG repeats ranged from 11 to 19 in Thai patients with
malaria. Among the eight identified alleles, in3(TG)12,
in3(TG)13, and in3(TG)16 were dominant in the studied
population (at frequencies of 32.0%, 31.5%, and
24.6%, respectively, in patients with mild malaria). The
frequency of in3(TG)12 was significantly higher in pa-
tients with mild malaria than in those with cerebral ma-
laria ( ; 95% CI 0.40–0.87; ) (ta-ORp 0.59 Pp .0069
ble 3). There was a significant reduction in the risk of
cerebral malaria in genotypes with in3(TG)12 (Pp
, by x2 test for trend) (table 4). Note that in3(TG)12.0097
showed a smaller P value than did 5′flankingSNP1 and
5′flankingSNP3. Neither allele frequency nor genotype
frequency showed a significant difference between pa-
tients with noncerebral severe malaria and patients with
cerebral malaria or mild malaria.
The TG Repeat Polymorphism and Variant CD36
Transcript Produced by the Skipping of Exons 4 and 5
Among the identified polymorphisms, in3(TG)12
showed the most prominent association with the reduc-
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Table 3
Allele Frequencies of in3(TG)n of CD36 in Thai Patients with
Malaria
ALLELE
NO. (%) WITH
Cerebral
Malaria
( )2np 216
Noncerebral Severe
Malaria
( )2np 328
Mild Malaria
( )2np 406
in3(TG)11 10 (4.6) 18 (5.5) 16 (3.9)
in3(TG)12
a 47 (21.8) 97 (29.6) 130 (32.0)
in3(TG)13 73 (33.8) 105 (32.0) 128 (31.5)
in3(TG)14 5 (2.3) 4 (1.2) 3 (.7)
in3(TG)15 11 (5.1) 16 (4.9) 13 (3.2)
in3(TG)16 63 (29.2) 81 (24.7) 100 (24.6)
in3(TG)17 6 (2.8) 7 (2.1) 13 (3.2)
in3(TG)19 1 (.4) 0 3 (.7)
a ; 95% CI 0.40–0.87; , and (cerebral2ORp 0.59 x p 7.29 Pp .0069
malaria vs. mild malaria, by x2 test based on a contingency table).2#2
Figure 2 Pattern of LD in CD36. Pairwise LD between polymorphisms, as measured on the basis of D′, is represented. The graphs are
adjusted for physical distance. Regions of high and low degrees of LD are shown in red and blue, respectively. a, Pairwise D′ in Thai patients
with cerebral malaria (upward triangle) and mild malaria (downward triangle). b, Pairwise D′ in ED (upward triangle) and AD (downward
triangle) Americans.
tion in the risk of cerebral malaria. If in3(TG)12 directly
influences the pathogenesis of cerebral malaria, then the
consequence would be an abnormal splicing of the
CD36 transcript. A previous study has revealed that al-
ternative splicing transcripts of the CD36 gene were ob-
served in human PBMC (Kern et al. 1999). Of various
splicing transcripts, only the variant CD36 transcript
produced by the skipping of exons 4 and 5 (fig. 3a) was
reported to be expressed on the surface of HEL cells (an
erythroleukemia cell line) (Tang et al. 1994). To assess
the possible association between the splicing variant and
the genotypes of in3(TG)n, we examined their allelic ex-
pression pattern by RT-PCR (fig. 3b). Sequencing of the
products confirmed three transcripts: the variant tran-
script produced by the skipping of exons 4 and 5, the
transcript containing exons 2 and 3, and the internal
control GAPDH. The variant transcript was detected in
individuals without in3(TG)12. In contrast, no amplifi-
cation of the variant transcript was detected in homo-
zygotes for in3(TG)12 or in a heterozygote for in3(TG)11
and in3(TG)12. An intermediate level of the transcript
was observed in heterozygotes for in3(TG)11 or
in3(TG)12. For the CD36 transcript with exons 2 and 3,
there was no difference in expression levels between the
genotypes of in3(TG)n. These results suggest that shorter
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Table 4
Genotype Frequencies of in3(TG)12 in Thai Patients with Malaria
GENOTYPE
NO. (%) WITH
Cerebral
Malariaa
( )np 108
Noncerebral Severe
Malaria
( )np 164
Mild Malaria
( )np 203
in3(TG)12/in3(TG)12 7 (6.5) 16 (9.8) 24 (11.8)
in3(TG)12/others 33 (30.5) 65 (39.6) 82 (40.4)
Others/others 68 (63.0) 83 (50.6) 97 (47.8)
a , and (cerebral malaria vs. mild malaria, by x2 test for2x p 6.68 Pp .0097
trend).
Figure 3 The variant CD36 transcript produced by exon skip-
ping. a, Schematic representation of alternative splicing ofCD36, caus-
ing the variant CD36 transcript. b, Expression of the variant CD36
transcript that lacks exons 4 and 5 was examined by RT-PCR with
cDNAs from human PBMC. Numbers above each lane refer to the
genotypes of in3(TG)n; for example, “16/16” is homozygous for
in3(TG)16. In each case, PCR products of the expected sizes were ob-
served for the variant CD36 transcript that lacks exons 4 and 5 (top),
the CD36 transcript from exons 2 and 3 (middle), and GAPDH (bot-
tom). The PCR products were separated on 10% polyacrylamide gel
and were stained by Syber Gold (Molecular Probes).
repeat alleles, such as in3(TG)11 and in3(TG)12, are in-
volved in the nonproduction of the variant CD36 tran-
script lacking exons 4 and 5 but that other alleles are
committed to the production of the variant transcript.
Haplotype Estimation
In the CD36 gene, 14 polymorphisms were identified.
Of these polymorphisms, 10 (shown in boldface in fig.
1) were used for haplotype estimation in Thai patients
with malaria. Figure 4 shows seven haplotypes, each of
which consist of 10 polymorphisms that have been
inferred to occur at a frequency 13%. These seven
haplotypes accounted for ∼70% of all haplotypes esti-
mated in the studied population. The C allele of
5′flankingSNP1, the T allele of 5′flankingSNP3, and
in3(TG)12 were found to be together on haplotypes A
and B.
Seven common haplotypes were inferred in Thai pa-
tients with malaria, whereas only three major haplotypes
(A  B, C  D, and E  F  G) were observed in the
region from 5′flankingSNP1 to in3SNP5. Interestingly,
these three haplotypes could also be distinguished by
means of the alleles of the TG repeat. Two haplotypes
(A  C  E  F and B  D  G) were inferred in the
region from in8SNP1 to in14Indel2. These results in-
dicate that there are two blocks with low haplotype di-
versity in the CD36 gene.
Although we cannot statistically compare the esti-
mated frequency of haplotype A or haplotype B between
patients with cerebral and mild malaria, the estimated
frequencies of both haplotypes were decreased in pa-
tients with cerebral malaria compared to those in pa-
tients with mild malaria. This observation supports
the hypothesis that in3(TG)12 itself or one or more
primary variants on the haplotype with in3(TG)12 may
be responsible for protection from cerebral malaria in
Thailand.
Discussion
Our study showed a significant association between
polymorphisms of the human CD36 gene and the se-
verity of malaria. Analysis of LD profiles indicated that,
in the CD36 gene, there are two blocks with strong LD
and the polymorphism (or polymorphisms) that provides
protection from cerebral malaria is in the upstream
block, spanning 35 kb. The in3(TG)n polymorphism in
this block showed a promising association with protec-
tion from cerebral malaria, and it has been suggested
that in3(TG)n is involved in the production of the variant
CD36 transcript without exons 4 and 5.
In the present study, in3(TG)12 was shown to be most
strongly associated with the significant reduction in the
risk of cerebral malaria. Although the functional sig-
nificance of in3(TG)n remains unclear, one of the TG
repeat alleles is known to be linked with the platelet-
specific regulation of CD36 (Kashiwagi et al. 1995).
Our results suggest that in3(TG)12 is involved in the
nonproduction of the variant CD36 transcript but that
other alleles may produce the transcript, causing the
expression of the CD36 isoform. The splicing out of
exons 4 and 5 maintains the reading frame, and the
translated product is expected to yield the CD36 iso-
form that lacks 103 amino acid residues (residues
41–143). Such an alternative splicing is likely to alter
the binding affinity of P. falciparum–infected erythro-
cytes for CD36, because exons 3, 5, and 6 of CD36
encode the ligand-binding domains at amino acid po-
sitions 8–21, 97–110, and 145–171, (Asch et al. 1993;
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Figure 4 Overview of the seven most common haplotypes estimated in 203 patients with mild malaria and 108 patients with cerebral
malaria. The green boxes represent major alleles, and the yellow boxes represent minor alleles at biallelic sites. Mp patients with mild malaria;
C p patients with cerebral malaria.
Baruch et al. 1999), respectively. The CD36 isoform that
lacks 103 amino acid residues is suggested to be ex-
pressed on the surface of HEL cells (Tang et al. 1994).
Furthermore, the transient expression of the variant
CD36 cDNA in COS-1 cells (a monkey kidney cell line)
showed that COS-1 cells expressing the CD36 isoform
do not bind to the monoclonal antibody OKM5 (Tang
et al. 1994), which specifically blocks CD36-mediated
adherence of P. falciparum–infected erythrocytes (Barn-
well et al. 1985). Thus, the epitope recognized by
OKM5 is altered by the lack of amino acids, suggesting
that the binding region for P. falciparum–infected eryth-
rocytes should also be affected in the CD36 isoform. A
recent study has revealed that CD36 on monocytes and
macrophages plays a crucial role in the CD36-depen-
dent phagocytosis of P. falciparum–infected erythro-
cytes and in protective immunity against malaria
(McGilvray et al. 2000). Considering these earlier re-
sults together with our results, we can hypothesize that
in3(TG)12, which does not produce the CD36 isoform,
is associated with protection from cerebral malaria be-
cause of the efficient phagocytosis mediated by intact
CD36.
The other, shorter allele, in3(TG)11, was also sug-
gested to be involved in the nonproduction of the var-
iant CD36 transcript, although in3(TG)11 did not show
a significant association with protection from cerebral
malaria. Because of low frequency of this allele, the
sample size in the association test might have been too
small for the detection of statistically significant differ-
ence, even if in3(TG)11 is truly associated with protec-
tion from cerebral malaria. Thus, further investigation
will be required in order to address this issue.
Analysis of LD profiles in three populations revealed
that there are two blocks with strong LD in the CD36
gene (fig. 2), and the region responsible for protection
from cerebral malaria was indicated to be in the 35-kb
upstream block, from the upstream promoter region to
exon 8. The upstream and downstream promoter
regions have been suggested to contain various common
regulatory elements of eukaryotic genes (Armesilla et
al. 1996; Sato et al. 2002). The 5′ UTR of the CD36
transcript was reported to play a crucial role in the
regulation of CD36 expression (Griffin et al. 2001) at
the translation level, and its secondary structure was
suggested to be involved in the translational efficiency
of CD36. In addition, the ligand-binding domain for P.
falciparum–infected erythrocytes was encoded by exons
in this block. On the basis of our findings and the bi-
ological significance of the upstream block of CD36,
this block is the most plausible candidate for the region
responsible for protection from cerebral malaria. In the
present study, no polymorphism that shows a P value
smaller than that of in3(TG)12 was identified by varia-
tion screening of two promoter regions and all exons
with neighboring introns in this block. Therefore, we
conclude that in3(TG)12 itself may be responsible for
protection from cerebral malaria in Thailand—although
we cannot exclude the possibility of the presence of
other primary polymorphisms on the haplotype with
in3(TG)12, because not all the introns and promoter
regions were investigated in the present study.
The LD pattern of the CD36 gene indicated that there
are two blocks with strong LD in Thai patients with
malaria. To determine whether this structure of LD is
observed in other human populations, we analyzed the
higher-resolution LD profiles, in AD and ED Americans,
that were based on genotype data from the UW-FHCRC
Variation Discovery Resource. Both populations
showed similar LD profiles with similar breakpoints
around exon 8 of CD36. There is considerable evidence
that recombination sites in humans are not randomly
distributed but are often localized in specific hotspots
(Jeffreys et al. 2001; Petes 2001). Jeffreys et al. (2001)
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observed three blocks with significantly increased D′ in
the class II human leukocyte antigen region and deter-
mined the crossover rates in the three hotspots; they
indicated that the LD profile could be used to predict
the locations of putative recombination hotspots. Be-
cause of the different population histories of AD and
ED Americans and Thai, it seems difficult to explain
the present observations in terms of population admix-
ture, subdivision, and bottlenecks. There must be an
essential mechanism, probably a recombination hot-
spot, that underlies the generation of a unique feature
of the LD profile of the CD36 gene. In the predicted
region of the recombination hotspot, the fraction of GC
content (36.0%) was lower than the average (41.0%)
for the human genome, and two Alu sequences facing
each other in intron 8 of CD36 (nucleotides 21038–
21343 and 21631–21938 in GenBank clone AY095373)
were found. These observations are consistent with pre-
vious reports on the recombination hotspot (Jeffreys et
al. 2001; Kong et al. 2002). Thus, we propose the ex-
istence of a recombination hotspot within 3 kb of exon
8 of the CD36 gene.
Our results have implications for disease-gene map-
ping, particularly for genomewide LD testing through
use of SNP markers. The potential for success when
using such testing depends on haplotype structure in the
region where a disease variant is located. We found that
in3(TG)12 is located on one of three major haplotypes
in the upstream block of LD. These haplotypes are char-
acterized by two SNPs (e.g., 5′flankingSNP1 and
5′UTRSNP2) with a high-frequency minor allele, and
each haplotype corresponds to each allele of the TG
repeat polymorphism (fig. 4). This observation suggests
that similar haplotypes in a block of strong LD were
derived from a common ancestral haplotype and have
been inherited without recombination. If a disease-
associated variant has, by mutation, arisen in such a
haplotype block, then the association would be detected
easily by the surrounding SNP markers in genomewide
LD testing.
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